These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26386788)

  • 1. Granulocyte-colony stimulating factor for large anterior ST-elevation myocardial infarction: rationale and design of the prospective randomized phase III STEM-AMI OUTCOME trial.
    Achilli F; Malafronte C; Cesana F; Maggiolini S; Mauro C; De Ferrari GM; Lenatti L; Tespili M; Pasqualini P; Gentile F; Capogrossi MC; Maggioni A; Maseri A; Pontone G; Colombo GI; Pompilio G;
    Am Heart J; 2015 Oct; 170(4):652-658.e7. PubMed ID: 26386788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cells mobilization in acute myocardial infarction (stem-AMI trial): preliminary data of a perspective, randomized, single blind trial.
    Malafronte C; Achilli F
    Minerva Cardioangiol; 2007 Dec; 55(6):721-31. PubMed ID: 18091641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
    Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
    Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
    Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
    Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
    Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-CSF treatment for STEMI: final 3-year follow-up of the randomised placebo-controlled STEM-AMI trial.
    Achilli F; Malafronte C; Maggiolini S; Lenatti L; Squadroni L; Gibelli G; Capogrossi MC; Dadone V; Gentile F; Bassetti B; Di Gennaro F; Camisasca P; Calchera I; Valagussa L; Colombo GI; Pompilio G;
    Heart; 2014 Apr; 100(7):574-81. PubMed ID: 24415665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-CSF for Extensive STEMI.
    Achilli F; Pontone G; Bassetti B; Squadroni L; Campodonico J; Corrada E; Facchini C; Mircoli L; Esposito G; Scarpa D; Pidello S; Righetti S; Di Gennaro F; Guglielmo M; Muscogiuri G; Baggiano A; Limido A; Lenatti L; Di Tano G; Malafronte C; Soffici F; Ceseri M; Maggiolini S; Colombo GI; Pompilio G;
    Circ Res; 2019 Jul; 125(3):295-306. PubMed ID: 31138020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial.
    Leone AM; D'Amario D; Teofili L; Basile E; Cannata F; Graziani F; Marzilli M; Russo AM; Tarantini G; Ceconi C; Leone G; Trani C; Rebuzzi AG; Crea F
    Trials; 2016 Feb; 17():97. PubMed ID: 26891753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
    Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
    Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.
    Zohlnhöfer D; Ott I; Mehilli J; Schömig K; Michalk F; Ibrahim T; Meisetschläger G; von Wedel J; Bollwein H; Seyfarth M; Dirschinger J; Schmitt C; Schwaiger M; Kastrati A; Schömig A;
    JAMA; 2006 Mar; 295(9):1003-10. PubMed ID: 16507801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial.
    Achilli F; Malafronte C; Lenatti L; Gentile F; Dadone V; Gibelli G; Maggiolini S; Squadroni L; Di Leo C; Burba I; Pesce M; Mircoli L; Capogrossi MC; Di Lelio A; Camisasca P; Morabito A; Colombo G; Pompilio G;
    Eur J Heart Fail; 2010 Oct; 12(10):1111-21. PubMed ID: 20861135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Different Bone Marrow-Derived Stem Cell Approaches in Reperfused STEMI. A Multicenter, Prospective, Randomized, Open-Labeled TECAM Trial.
    San Roman JA; Sánchez PL; Villa A; Sanz-Ruiz R; Fernandez-Santos ME; Gimeno F; Ramos B; Arnold R; Serrador A; Gutiérrez H; Martin-Herrero F; Rollán MJ; Fernández-Vázquez F; López-Messa J; Ancillo P; Pérez-Ojeda G; Fernández-Avilés F
    J Am Coll Cardiol; 2015 Jun; 65(22):2372-82. PubMed ID: 26046730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial).
    Mewton N; Cung TT; Morel O; Cayla G; Bonnefoy-Cudraz E; Rioufol G; Angoulvant D; Guerin P; Elbaz M; Delarche N; Coste P; Vanzetto G; Metge M; Aupetit JF; Jouve B; Motreff P; Tron C; Labeque JN; Steg PG; Cottin Y; Range G; Clerc J; Coussement P; Prunier F; Moulin F; Roth O; Belle L; Dubois P; Barragan P; Gilard M; Piot C; Colin P; Morice MC; Monassier JP; Ider O; Dubois-Randé JL; Unterseeh T; Lebreton H; Beard T; Blanchard D; Grollier G; Malquarti V; Staat P; Sudre A; Hansson MJ; Elmer E; Boussaha I; Jossan C; Torner A; Claeys M; Garcia-Dorado D; Ovize M;
    Am Heart J; 2015 Jun; 169(6):758-766.e6. PubMed ID: 26027612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Thrombus Formation After ST-Segment-Elevation Myocardial Infarction: Insights From a Cardiac Magnetic Resonance Multicenter Study.
    Pöss J; Desch S; Eitel C; de Waha S; Thiele H; Eitel I
    Circ Cardiovasc Imaging; 2015 Oct; 8(10):e003417. PubMed ID: 26481162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study).
    Leone AM; Galiuto L; Garramone B; Rutella S; Giannico MB; Brugaletta S; Perfetti M; Liuzzo G; Porto I; Burzotta F; Niccoli G; Biasucci LM; Leone G; Rebuzzi AG; Crea F
    Am J Cardiol; 2007 Aug; 100(3):397-403. PubMed ID: 17659916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: one-year follow-up of a phase 1 study.
    Santoso T; Irawan C; Alwi I; Aziz A; Kosasih A; Inggriani S; Saputra A; Wintery M; Lison L
    Acta Med Indones; 2011 Apr; 43(2):112-21. PubMed ID: 21785174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial.
    Prunier F; Bière L; Gilard M; Boschat J; Mouquet F; Bauchart JJ; Charbonnier B; Genée O; Guérin P; Warin-Fresse K; Durand E; Lafont A; Christiaens L; Abi-Khalil W; Delépine S; Benard T; Furber A
    Am Heart J; 2012 Feb; 163(2):200-7.e1. PubMed ID: 22305837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Patel MR; Westerhout CM; Granger CB; Brener SJ; Fu Y; Siha H; Kim RJ; Armstrong PW
    Am Heart J; 2013 Feb; 165(2):226-33. PubMed ID: 23351826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between discharge heart rate and left ventricular adverse remodelling in ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Joyce E; Hoogslag GE; Leong DP; Fox K; Schalij MJ; Marsan NA; Bax JJ; Delgado V
    Heart; 2013 Apr; 99(8):556-61. PubMed ID: 23468514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans.
    Nienaber CA; Petzsch M; Kleine HD; Eckard H; Freund M; Ince H
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S73-7. PubMed ID: 16501636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.